Pipeline

PCUT BioPartners is interested in drug programs that have solid rationale and appropriate evidence supporting clinical trial in life-threatening diseases.

We are actively pursuing three clinical candidates in the neurodegenerative disease space.

Our interests include therapeutics in several classes of diseases. One of our non-profit affiliates has compiled a list of over 40 medically promising products that have been directed at unmet medical needs and have stalled in development for non-health related reasons. As we review these, we will continue to engage other companies and disease-specific foundations to find undervalued drug programs.

 

 

 

 

Sample Cost Partnership

Chart

  • 1% Prospect Sourcing from Non Profit Organizations

  • 24% Product Development Team and Contract Research

  • 25% Contract Manufacturing

  • 50% PCUT BioPartners, Inc.

Click here to download detailed "Cost Partnership PDF"